GRADE Evidence to Decision (EtD) frameworks: A systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines

The BMJ

Volumn 353, Issue , 2016, Pages

  Alonso Coello, Pablo ^a,b   Oxman, Andrew D ^c   Moberg, Jenny ^c   Brignardello Petersen, Romina ^b,d   Akl, Elie A ^b,e   Davoli, Marina ^f   Treweek, Shaun ^g   Mustafa, Reem A ^b,h   Vandvik, Per O ^c   Meerpohl, Joerg ⁱ   Guyatt, Gordon H ^b   Schünemann, Holger J ^b   Etxeandia Ikobaltzeta, Itziar ^j   Ibargoyen Roteta, Nora ^j   Reyes, María Ximena Rojas ^j   Parmelli, Elena ^j   Pottie, Kevin ^j   Rigau, David ^j   Rosenbaum, Sarah ^j   Sanabria, Andrea Juliana ^j   Singh, Jasvinder ^j   Stanev, Roger ^j   Vernooij, Robin W ^j   Verstijnen, Ilse ^j   more..

^a CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^b MCMASTER UNIVERSITY   (Canada)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d UNIVERSITY OF CHILE   (Chile)

^e AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^f DEPARTMENT OF EPIDEMIOLOGY   (Italy)

^g UNIVERSITY OF ABERDEEN   (United Kingdom)

^h UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF FREIBURG   (Germany)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

DABIGATRAN; WARFARIN;

ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; FECES MICROFLORA; HEALTH CARE; HEALTH CARE SYSTEM; HUMAN; INTERNATIONAL NORMALIZED RATIO; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; COST BENEFIT ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE PLANNING; PROCEDURES; PROGRAM DEVELOPMENT;

CHOICE BEHAVIOR; COST-BENEFIT ANALYSIS; DECISION MAKING; EVIDENCE-BASED MEDICINE; HEALTH PLAN IMPLEMENTATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; PROGRAM DEVELOPMENT;

EID: 84977504852     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i2089     Document Type: Article

References (32)

1. Institute of Medicine. Clinical practice guidelines we can trust. National Academies Press, 2011, p4. http://books.nap.edu/ openbook.php? record-id=13058&page=4
2. Laine C, Taichman DB, Mulrow C. Trustworthy clinical guidelines. Ann Intern Med 2011;154:774-5. doi:10.7326/0003-4819-154-11-201106070-00011.
3. Qaseem A, Forland F, Macbeth F, Ollenschläger G, Phillips S, van der Wees P. Board of Trustees of the Guidelines International Network. Guidelines International Network: toward international standards for clinical practice guidelines. Ann Intern Med 2012;156:525-31. doi:10.7326/0003-4819-156-7-201204030-00009.
4. Schünemann HJ, Wiercioch W, Etxeandia I, et al. Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ 2014;186:E123-42. doi:10.1503/cmaj.131237.
5. Alonso-Coello P, Schunemann H, Moberg J, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ 2016;353:i2016. doi:10.1136/bmj.i2016.
6. Connolly SJ, Ezekowitz MD, Yusuf S, et al. RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51. doi:10.1056/NEJMoa0905561.
7. Patel MR, Mahaffey KW, Garg J, et al. ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883-91. doi:10.1056/NEJMoa1009638.
8. Granger CB, Alexander JH, McMurray JJ, et al. ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981-92. doi:10.1056/ NEJMoa1107039.
9. Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club 1995;123:A12-3.
10. Treweek S, Oxman AD, Alderson P, et al. DECIDE Consortium. Developing and Evaluating Communication Strategies to Support Informed Decisions and Practice Based on Evidence (DECIDE): protocol and preliminary results. Implement Sci 2013;8:6. doi:10.1186/1748-5908-8-6.
11. Rosenbaum SE. Improving the user experience of evidence. A design approach to evidence-informed health care.Oslo College of Architecture and Design, 2010: 108-16.
12. Morville P. User experience design. Sematic Studios LLC, 2004. www. semanticstudios.com/publications/semantics/000029.php
13. Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 2013;66:719-25. doi:10.1016/j.jclinepi.2012.03.013.
14. Andrews JC, Schünemann HJ, Oxman AD, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol 2013;66:726-35. doi:10.1016/j.jclinepi.2013.02.003.
15. Guyatt GH, Oxman AD, Kunz R, et al. GRADE Working Group. Going from evidence to recommendations. BMJ 2008;336:1049-51. doi:10.1136/bmj.39493.646875.AE.
16. Wallentin L, Yusuf S, Ezekowitz MD, et al. RE-LY investigators. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet 2010;376:975-83. doi:10.1016/S0140-6736(10)61194-4.
17. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011;64:383-94. doi:10.1016/j.jclinepi.2010.04.026.
18. Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011;64:401-6. doi:10.1016/j.jclinepi.2010.07.015.
19. Guyatt GH, Oxman AD, Sultan S, et al. GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol 2013;66:151-7. doi: 10.1016/j. jclinepi.2012.01.006.
20. Sun X, Ioannidis JP, Agoritsas T, Alba AC, Guyatt G. How to use a subgroup analysis: users' guide to the medical literature. JAMA 2014;311:405-11. doi:10.1001/jama.2013.285063.
21. MacLean S, Mulla S, Akl EA, et al. American College of Chest Physicians. Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(Suppl):e1S-23S. doi:10.1378/chest.11-2290.
22. Earle CC, Chapman RH, Baker CS, et al. Systematic overview of cost-utility assessments in oncology. J Clin Oncol 2000;18:3302-17.
23. Hall J, Gerard K, Salkeld G, Richardson J. A cost utility analysis of mammography screening in Australia. Soc Sci Med 1992;34:993-1004. doi:10.1016/0277-9536(92)90130-I.
24. Hamidi V, Wisløff T, Ringerike T, Linnestad KK, Harboe I, Klemp M. [Treatment of patients with acute stroke in stroke units (with or without early supported discharge)]. Rapport fra Kunnskapssenteret nr 18-2010. Oslo: Nasjonalt kunnskapssenter for helsetjenesten, 2010. www.kunnskapssenteret.no/ Publikasjoner/-attachment/10097
25. Brunetti M, Shemilt I, Pregno S, et al. GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence. J Clin Epidemiol 2013;66:140-50. doi:10.1016/j. jclinepi.2012.04.012.
26. Sorensen SV, Peng S, Monz BU, Bradley-Kennedy C, Kansal AR. A comparative analysis of models used to evaluate the costeffectiveness of dabigatran versus warfarin for the prevention of stroke in atrial fibrillation. Pharmacoeconomics 2013;31:589-604. doi:10.1007/s40273-013-0035-8.
27. Dans AM, Dans LF, Oxman AD, et al. Addressing inequities in clinical practice guidelines. Clin Epidemiol 2007;60:540-6.doi:10.1016/j. jclinepi.2006.10.008.
28. Oxman AD, Schünemann HJ, Fretheim A. Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity. Health Res Policy Syst 2006;4:24. doi:10.1186/1478-4505-4-24.
29. Beauchamp TL, Childress JF. Principles of biomedical ethics.7th ed. Oxford University Press, 2013.
30. Saarni SI, Braunack-Mayer A, Hofmann B, van der Wilt GJ. Different methods for ethical analysis in health technology assessment: an empirical study. Int J Technol Assess Health Care 2011;27:305-12. doi:10.1017/S0266462311000444.
31. Flottorp SA, Oxman AD, Krause J, et al. A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice. Implement Sci 2013;8:35. doi:10.1186/1748-5908-8-35.
32. Fretheim A, Oxman AD, Lavis JN, Lewin S. SUPPORT tools for evidenceinformed policymaking in health 18: Planning monitoring and evaluation of policies. Health Res Policy Syst 2009;7(Suppl 1):S18. doi:10.1186/1478-4505-7-S1-S18.